by Benzinga Insights | Oct 2, 2026 | General
Cogent Biosciences (NASDAQ:COGT) has outperformed the market over the past 5 years by 16.44% on an annualized basis producing an average annual return of 28.63%. Currently, Cogent Biosciences has a market capitalization of $5.38 billion. Buying $1000 In COGT: If an...
by Chandrima Sanyal | Oct 2, 2026 | General
SpaceX’s (NASDAQ:SPCX) latest launch streak is fueling a powerful move across a new generation of leveraged ETFs tied directly to the rocket company, with several funds among the market’s strongest performers Friday. Defiance Daily Target 2X Long SPCX ETF (BATS:SPCU),...
by Chris Katje | Oct 2, 2026 | General
When it comes to small-cap defense stocks, Everforth (NYSE:EFOR) is likely among the companies most investors have never heard of. Whether President Donald Trump has ever heard of the stock, it’s likely in his investment portfolio today. • Everforth stock is showing...
by Neeraj Jain | Oct 2, 2026 | General
Major U.S. retailers are navigating an uneven, challenging inflation environment, with higher fuel, transportation, and supplier costs continuing to pressure operating costs and margins. Retailers’ responses remain varied in relation to setting consumer prices and in...
by Henry Khederian | Oct 2, 2026 | General
Shares of Caterpillar Inc. (NYSE:CAT) are trading higher Friday afternoon as investors weigh fresh developments supporting the broader artificial intelligence infrastructure buildout, while a sharp pullback in expectations for another Federal Reserve interest-rate...
Recent Comments